Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Bonus plan approved
Inv. presentation
Acq. announced
Director departure
|
|
CUBIST PHARMACEUTICALS INC (CBST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/18/2013 |
8-K/A
| Financial Statements and Exhibits |
| 11/22/2013 |
8-K/A
| Financial Statements and Exhibits |
| 02/27/2012 |
8-K/A
| Financial Statements and Exhibits |
| 09/21/2011 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 02/26/2010 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Ernst & Young LLP, Independent Auditors",
"Audited financial statements of Calixa as of December 31, 2008 and 2007, and for the fiscal year ended December 31, 2008, and for the periods from July 11, 2007, (inception) to December 31, 2007 and 2008",
"Unaudited financial statements of Calixa as of September 30, 2009, and for the nine months ended September 30, 2009 and 2008",
"Unaudited pro forma condensed combined consolidated financial statements" |
|
| 03/13/2008 |
8-K/A
| Financial Statements and Exhibits |
| 01/08/2001 |
8-K/A
| Acquisition or disposition of assets, Financial statements and exhibits |
|
|